Replies to post #54 on Premarketerzzz

[shakerzzz]

ISPH shares likely to settle around $4, says Leerink
Leerink finds the denufosol trial failure as highly unexpected and expects ire Pharma shares to settle around $4. The firm estimates Inspire's eye drugs business at roughly $3 per share and the company's cash position at $1 per share